Robert Iannone

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
1 year
Director since
2026

1 year of board service in total across 2 boards, counting each seat separately. Longest: Autolus Therapeutics plc American Depositary Share, 8 months.

8 months · Since 2026
4 months · Since 2026

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 27, 2026 Jazz Pharmaceuticals plc Option exercise +26,116 $113.10 $2,953,720
Aug 27, 2026 Jazz Pharmaceuticals plc Option exercise +884 $113.10 $99,980
Aug 27, 2026 Jazz Pharmaceuticals plc Option exercise +27,584 $137.12 $3,782,318
Aug 27, 2026 Jazz Pharmaceuticals plc Option exercise +2,916 $137.12 $399,842
Aug 27, 2026 Jazz Pharmaceuticals plc Open-market sale −18,187 $247.86 $4,507,830
Aug 27, 2026 Jazz Pharmaceuticals plc Open-market sale −11,423 $248.67 $2,840,557
Aug 27, 2026 Jazz Pharmaceuticals plc Open-market sale −18,113 $250.02 $4,528,612
Aug 27, 2026 Jazz Pharmaceuticals plc Open-market sale −19,639 $250.60 $4,921,533
Aug 27, 2026 Jazz Pharmaceuticals plc Open-market sale −9,259 $251.95 $2,332,805
Aug 27, 2026 Jazz Pharmaceuticals plc Open-market sale −300 $252.76 $75,828
Jun 30, 2026 Jazz Pharmaceuticals plc Shares withheld for tax −3,764 $237.72 $894,778
Mar 5, 2026 Jazz Pharmaceuticals plc Shares withheld for tax −6,209 $188.69 $1,171,576
Feb 26, 2026 Jazz Pharmaceuticals plc Grant or award +14,822 — —
Jan 16, 2026 Jazz Pharmaceuticals plc Grant or award +11,699 — —
Jan 16, 2026 Jazz Pharmaceuticals plc Shares withheld for tax −4,140 $171.16 $708,602

Questions about Robert Iannone

What boards is Robert Iannone on?

Robert Iannone sits on the boards of Autolus Therapeutics plc American Depositary Share and Pliant Therapeutics Inc.

How long has Robert Iannone served on boards?

Our records show at least 1 year of board service across 2 boards, the earliest from 2026.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.